Speaker Details

John Harris, MD, PhD, FAAD

John Harris, MD, PhD, FAAD

SESSIONS

S006 Vitiligo
Mar 7, 2025 9:00 AM - 12:00 PM W308A
S024 Inflammatory Skin Diseases: The Translational Revolution
Mar 8, 2025 9:00 AM - 12:00 PM W209C

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aclaris Therapeutics, Inc. – Consultant(Fees); Aldena Therapeutics – Consultant(Fees), Founder(Stock); Almirall – Consultant(Fees); Alys Pharmaceuticals – Founder(Salary), Stockholder Private Company(Fees); Bain Capital – Consultant (1099 relationship)(Fees); Barinthus Biotherapeutics North America, Inc. – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Boxer Capital Management, LLC – Consultant (1099 relationship)(Fees); Cour Pharmaceuticals – Investigator(Grants/Research Funding); Dren Bio – Investigator(Grants/Research Funding); Granular Therapeutics – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Klirna Biotech, Inc. – Founder(Stock); Klirna Therapeutics – Founder(Stock); Leo Pharma Inc – Investigator(Grants/Research Funding); NexImmune – Investigator(Grants/Research Funding); Nira Biosciences, Inc. – Consultant(Fees), Founder(Stock); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Villaris Therapeutics, Inc – Founder(Stock), Investigator(Grants/Research Funding); Vimela – Consultant(Honoraria), Stockholder(Stock); Vividion Therapeutics – Consultant (1099 relationship)(Fees);